Skip to content

OPtical Frequency Domain Imaging Versus INtravascular Ultrasound in Percutaneous Coronary InterventiON - OPINION Imaging

OPtical Frequency Domain Imaging vs. INtravascular Ultrasound in Percutaneous Coronary InterventiON - OPINION Imaging

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01873222
Enrollment
106
Registered
2013-06-10
Start date
2013-06-30
Completion date
2016-07-31
Last updated
2016-07-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Artery Disease

Keywords

Coronary Artery Disease, Percutaneous Coronary Intervention, Optical Frequency Domain Imaging, Intravascular Ultrasound

Brief summary

This study is the sub-study of OPINION Trial. (UMIN000010580) The aim of this study is to evaluate how Optical frequency domain imaging (OFDI) or Intravascular Ultrasound (IVUS) imaging technology influence to the Percutaneous Coronary Intervention (PCI) strategy.

Detailed description

Optical frequency domain imaging (OFDI) is a novel, high resolution intravascular imaging modality. Intravascular ultrasound (IVUS) is a widely used conventional imaging modality for achieving optimal stent deployment. This study is the sub-study of OPINION Trial. (UMIN000010580) The aim of this study is to evaluate how OFDI or IVUS imaging technology influence to the Percutaneous Coronary Intervention (PCI) strategy. We will enroll the first 100 patients who have enrolled in the main-study of OPINION trial.(UMIN000010580). We will assess lesions by the other device in addition to the assigned device in the main study at the time of post-PCI. We will then assess lesions by OFDI at a 8-month follo-up.

Interventions

DEVICEOFDI-guided PCI & IVUS

* Assessment by IVUS at post-PCI * Assessment by OFDI at a 8-month follow-up

DEVICEIVUS-guided PCI & OFDI

* Assessment by OFDI at post-PCI * Assessment by OFDI at a 8-month follow-up

Sponsors

Wakayama Medical University
CollaboratorOTHER
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
20 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* Patients participating in the OPINION Trial * Patients who has provided written informed consent

Exclusion criteria

* Ineligible patients according to the investigator's judgment * Inability or unwillingness to perform required follow up procedures

Design outcomes

Primary

MeasureTime frameDescription
Minimum stent area by OFDIat just after the PCIThe investigators will assess Minimum stent area by OFDI at post-PCI.
Frequency of malapposed strutsat just after the PCIThe investigators will assess Frequency of malapposed struts by OFDI at post-PCI.
Dissectionat just after the PCIThe investigators will assess Dissection by OFDI at post-PCI.
Minimum stent area by IVUSat just after the PCIThe investigators will assess Minimum stent area by IVUS at post-PCI.
Frequency of uncovered struts8 months after PCIThe investigators will assess Frequency of uncovered struts by OFDI at 8 months after PCI.
Minimum lumen area8-month follow-up after PCIThe investigators will assess Minimum lumen area by OFDI at 8 months after PCI.

Countries

Japan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 26, 2026